Business Wire

Cognito Therapeutics Phase 2 OVERTURE Study MRI Imaging Analysis Published in Journal of Alzheimer’s Disease

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, announced today publication of MRI imaging ...
EurekAlert!

MRI pioneer wins national physics prize

College Park, MD-September 21, 2005--With its ability to obtain detailed pictures from the depths of the living body, magnetic resonance imaging (MRI) has saved many lives and dramatically increased ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Hosted on MSN

GE HealthCare’s manganese-based MRI contrast agent shines in Phase I trial

GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Data from the first-in-human trial – presented at ...
AZOM

Introduction to Ultrasonic Phased Array Testing

In the medical applications of ultrasonic imaging, sound waves of high frequency are usually employed to produce in-depth cross-sectional images of internal organs. Special multi-element transducers ...